Impact of insomnia and obstructive sleep apnea on the risk of acute exacerbation of chronic obstructive pulmonary disease

Sleep Med Rev. 2021 Aug:58:101444. doi: 10.1016/j.smrv.2021.101444. Epub 2021 Jan 29.

Abstract

Chronic obstructive pulmonary disease (COPD) is a major health burden worldwide. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is characterized by worsening of patients' respiratory symptoms that requires a modification in medication. This event could accelerate disease progression and increase the risk of hospital admissions and mortality. Both insomnia and obstructive sleep apnea (OSA) are prevalent in patients with COPD, and are linked to increased susceptibility to AECOPD. Improper treatment of insomnia may increase the risk of adverse respiratory outcomes for patients with COPD, while effective continuous positive airway pressure (CPAP) treatment may reduce the risk of AECOPD and mortality in patients with overlap syndrome. Sleep disorders should be considered in clinical management for COPD.

Keywords: Chronic obstructive pulmonary disease; Exacerbation; Insomnia; Obstructive sleep apnea.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Continuous Positive Airway Pressure
  • Humans
  • Pulmonary Disease, Chronic Obstructive* / complications
  • Sleep Apnea, Obstructive* / complications
  • Sleep Apnea, Obstructive* / therapy
  • Sleep Initiation and Maintenance Disorders* / complications
  • Sleep Initiation and Maintenance Disorders* / therapy
  • Syndrome